MAXEON SOLAR TECHNOLOGIE (MAXN)

SGXZ25336314 - Common Stock

7.4  +0.81 (+12.29%)

After market: 7.16 -0.24 (-3.24%)

Fundamental Rating

1

MAXN gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. MAXN has a bad profitability rating. Also its financial health evaluation is rather negative. MAXN has a expensive valuation and it also scores bad on growth.



0

1. Profitability

1.1 Basic Checks

MAXN had negative earnings in the past year.
MAXN had a negative operating cash flow in the past year.
MAXN had negative earnings in each of the past 5 years.
MAXN had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

With a Return On Assets value of -47.51%, MAXN is not doing good in the industry: 87.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -47.51%
ROE N/A
ROIC N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

MAXN does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

MAXN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MAXN has been reduced compared to 1 year ago.
Compared to 5 years ago, MAXN has less shares outstanding
MAXN has a worse debt/assets ratio than last year.

2.2 Solvency

MAXN has an Altman-Z score of -1.31. This is a bad value and indicates that MAXN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.31, MAXN is doing worse than 77.78% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -1.31
ROIC/WACCN/A
WACC7.99%

2.3 Liquidity

MAXN has a Current Ratio of 1.36. This is a normal value and indicates that MAXN is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.36, MAXN is not doing good in the industry: 82.41% of the companies in the same industry are doing better.
MAXN has a Quick Ratio of 1.36. This is a bad value and indicates that MAXN is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of MAXN (0.55) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.55

2

3. Growth

3.1 Past

The earnings per share for MAXN have decreased strongly by -20491.44% in the last year.
Looking at the last year, MAXN shows a very negative growth in Revenue. The Revenue has decreased by -34.57% in the last year.
Measured over the past years, MAXN shows a small growth in Revenue. The Revenue has been growing by 4.25% on average per year.
EPS 1Y (TTM)-20491.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4166.67%
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y9.96%
Revenue growth 5Y4.25%
Sales Q2Q%-47.12%

3.2 Future

Based on estimates for the next years, MAXN will show a very strong growth in Earnings Per Share. The EPS will grow by 25.99% on average per year.
The Revenue is expected to decrease by -2.18% on average over the next years.
EPS Next Y90.26%
EPS Next 2Y40.86%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year-45.86%
Revenue Next 2Y-23.09%
Revenue Next 3Y-2.18%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

1

4. Valuation

4.1 Price/Earnings Ratio

MAXN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year MAXN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

MAXN's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.86%
EPS Next 3Y25.99%

0

5. Dividend

5.1 Amount

No dividends for MAXN!.
Industry RankSector Rank
Dividend Yield N/A

MAXEON SOLAR TECHNOLOGIE

NASDAQ:MAXN (12/20/2024, 8:23:31 PM)

After market: 7.16 -0.24 (-3.24%)

7.4

+0.81 (+12.29%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)09-03 2024-09-03/bmo
Earnings (Next)N/A N/A
Inst Owners3.43%
Inst Owner Change112.58%
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap112.63M
Analysts46.67
Price Target57.25 (673.65%)
Short Float %24.89%
Short Ratio0.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-34.64%
Min EPS beat(2)-57.06%
Max EPS beat(2)-12.21%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.6%
Min Revenue beat(2)-5.22%
Max Revenue beat(2)2.03%
Revenue beat(4)1
Avg Revenue beat(4)-2.44%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)2.03%
Revenue beat(8)2
Avg Revenue beat(8)-3.14%
Revenue beat(12)4
Avg Revenue beat(12)-2.07%
Revenue beat(16)6
Avg Revenue beat(16)-1.49%
PT rev (1m)0%
PT rev (3m)2585.41%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-247.11%
EPS NY rev (1m)-205.02%
EPS NY rev (3m)-1043.29%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-43.5%
Revenue NY rev (1m)1.31%
Revenue NY rev (3m)-9.49%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-531.26
EYN/A
EPS(NY)-5.59
Fwd EYN/A
FCF(TTM)-28.84
FCFYN/A
OCF(TTM)-24.65
OCFYN/A
SpS54.41
BVpS-1.77
TBVpS-2.48
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -47.51%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-24.28%
ROA(5y)-21.17%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.08
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 132.9%
Cap/Sales 7.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.36
Quick Ratio 0.55
Altman-Z -1.31
F-Score2
WACC7.99%
ROIC/WACCN/A
Cap/Depr(3y)199.78%
Cap/Depr(5y)147.34%
Cap/Sales(3y)10.57%
Cap/Sales(5y)7.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20491.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-4166.67%
EPS Next Y90.26%
EPS Next 2Y40.86%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.57%
Revenue growth 3Y9.96%
Revenue growth 5Y4.25%
Sales Q2Q%-47.12%
Revenue Next Year-45.86%
Revenue Next 2Y-23.09%
Revenue Next 3Y-2.18%
Revenue Next 5YN/A
EBIT growth 1Y-351.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-22.85%
EBIT Next 3Y35.95%
EBIT Next 5YN/A
FCF growth 1Y-282.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2345.13%
OCF growth 3YN/A
OCF growth 5YN/A